Edition:
United Kingdom

Profile: Cardiex Ltd (CDX.AX)

CDX.AX on Australia Stock Exchange

0.02AUD
16 Aug 2019
Change (% chg)

$-0.00 (-14.81%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.03
Day's Low
$0.02
Volume
3,065,064
Avg. Vol
1,991,651
52-wk High
$0.07
52-wk Low
$0.02

Cardiex Ltd, formerly AtCor Medical Holdings Ltd, is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company's clinical trial services, include study protocol assistance, study-specific user manual, operator training and certification, study-specific training materials, automated data transfer for expert over-read, quality assurance, ongoing data management, technical support and sponsor-defined data transfers. The Company also offers SphygmoCor technology, which is used in clinical trials for a range of therapeutic areas, including hypertension, renal disease, heart failure, inflammatory processes, diabetes and chronic obstructive pulmonary disease (COPD).

Company Address

Cardiex Ltd

Unit 11 1059 - 1063 Victoria Roa
SYDNEY   NSW   2114

Company Web Links